Combination Products: Challenges and Expectations (T47)

Print this page         

Combination Products: Challenges and Expectations (T47)

Level: Intermediate
ISPE CEUs: 1.3
Type: Classroom Training Course

With the increasing regulatory scrutiny on combination products, this new highly interactive course provides six (6) different aspects of a combination product which are:

  1. Combination Product GMPs
  2. Criticality of Design Input and how to define the requirements
  3. Design Verification and Validation approaches
  4. What to expect and considerations for Clinical Trial for Combination Products
  5. Human Factors for Combination Products
  6. Post Market Considerations

An overview and the intricacies of the GMPs for combination products will be provided that specifically address the challenges and expectations from industry and global regulatory agencies. The development of the basis for the product, testing, and specifications including identifying design inputs, user requirements and design requirements as starting points to the development process will be reviewed in detail.

The course will also include how to test and how to determine the appropriate level of design validation for combination products, which has been a hot topic recently for regulatory bodies. Discussions and interactive sessions for the application of proper design of validation studies, which is critical to assuring that your customers are satisfied and can appropriately use your combination products, will be explored to provide insights into the development for designing validation studies. Additional content will address key questions regarding establishment of appropriate studies to assure that user requirements have been met.

Designing and executing a clinical trial for combination products, which often presents unique challenges, will be explored. To support the market authorization for a combination product, identifying common questions surrounding clinical trial design including sample size requirements, number and extent of clinical studies required, as well as claims that may be made based on the trials will be discussed. Case studies for use of drug delivery systems will be provided for an in-depth review.

Human Factors studies are an integral component of product development for most combination products today. This course will discuss the special considerations for designing formative and summative human factors studies for combination products, including unique user group requirements and how they are defined (elderly, visually impaired, pediatrics), sample size, and environmental use conditions. Course participants will review the US FDA’s perspective into common issues and challenges as well as how to address them, and how to best present the information.

Participants should be prepared to work in groups to prepare and organize human factors study data in preparation for a regulatory submission to facilitate a timely US FDA review.

The course will also consider the role of post-marketing safety surveillance and other design corrective and preventive action inputs in product design evolution and validation during the life-cycle of a device containing combination product.

Course Modules

  • Combination Products Definition and Classification
  • Jurisdiction, Regulatory Challenges, Regulations / Guidance
  • Design Controls
  • Design Verification and Validation
  • Human Factor Studies
  • Clinical Trials
  • Post Market Surveillance
  • Regulatory and Regulatory Challenges
  • Regulation and Guidance Documents
  • Case Studies designed as problem-based sessions to develop solutions

Take Back to Your Job

  • Clearly define and identify what constitutes a combination product.
  • Identify the correct global regulatory agencies, specific regulations and guidance documents applicable to combination products.
  • Review the current regulatory challenges for combination products and develop strategies.
  • Demonstrate the ability to prepare and maintain design elements.
  • Know how to design a verification/validation program for combination products.
  • Understand Human Factor Study data and be able to organize it for a submission.
  • Determine what specific components are needed for combination product clinical trials.
  • Understand the frequency of post market surveillance and how to analyze the required data.

Attendance Suggested For

Individuals working with Operations, Regulatory Affairs, Clinical Affairs, Manufacturing, Quality, Product and Process Development Engineering, and Project Management professionals.

Community of Practice (COP)

This training course is of particular interest to existing and future members of the ISPE Product and Process Development Communities of Practice (COPs).

SAVE hundreds of dollars on training by joining ISPE! Join now »

This course is not currently scheduled, but may be offered at your company site.

Please contact ISPE for more information.

Group Discounts

  • 3 - 5 participants - Save 10%
  • 6 - 10 participants - Save 15%
  • 11 or more participants - Save 20%

To qualify, all registrant information must be submitted at the same time; only ONE payment to cover all registrations will be accepted. Registrations that arrive later will NOT be eligible for the group discount. Cannot be combined with other offers. To register as a group, please contact ISPE by telephone, +1-813-960-2105.


  • Click to go to My Communities of Practice
  • Click to go to My Affiliate or Chapter
  • Click to go to My Profile



Chairman’s Chatter: Collaboration
Thursday, 20 Oct 2016 14.10

Moving to Single-Use Continuous Manufacturing
Wednesday, 19 Oct 2016 12.10

cGMP Crossroads: Intersection of University & Pharma Research
Tuesday, 18 Oct 2016 13.10